Ikarian Capital, LLC Ionis Pharmaceuticals Inc Call Options Transaction History

Ikarian Capital, LLC

3 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2021 Aug 16, 2021	SELL	$34.54 - $47.25 $3.11 Million - $4.25 Million	-90,000 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$42.51 - $63.78 $8.5 Million - $12.8 Million	-200,000 Reduced 68.97%	90,000 $4.05 Million
Q4 2020 Feb 12, 2021	BUY	$45.3 - $60.27 $13.1 Million - $17.5 Million	290,000 New	290,000 $16.4 Million

389

125M

2.25M

510K

Ticker IONS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,940,992
Market Cap $5.64B
Description
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...

Get notified when there are updates to the investment portfolio of Ikarian Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Ikarian Capital, LLC with notifications on news.